Chinook Therapeutics Competitors and Similar CompaniesClear all
Chinook Therapeutics's competitors and similar companies include Mesoblast, Sanesco, Dr Lal PathLabs and Spark Therapeutics.
 Chinook Therapeutics Chinook Therapeutics is a biopharmaceutical company that develops precision medicines for kidney diseases. |  Mesoblast Mesoblast specializes in the development of biologic products for the broad field of regenerative medicine. |  Sanesco Sanesco Health International is a biomedical company providing healthcare practitioners with clinical tools and products used for neuroendocrine health. |  Dr Lal PathLabs Dr Lal PathLabs is an international service provider of diagnostic and related healthcare tests. | ||
Founding Date | Founding Date 2011 | Founding Date 2004 | Founding Date 2004 | Founding Date 1949 | Founding Date 2013 |
Type | Type Subsidiary | Type Public | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Seattle, US HQ | Locations Melbourne, AU HQ Singapore, SG New York, US | Locations Arden, US HQ | Locations Gurugram, IN HQ | Locations Philadelphia, US HQ |
Employees | Employees 27 | Employees 73 | Employees 23 | Employees 4,099 | Employees 36817% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1.2 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 4.4 b |
Financial | |||||
Revenue (est.) | Revenue (est.) $6.1m (FY, 2022) | Revenue (est.) $17.2m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) ₹27.6b (FY, 2026) | Revenue (est.) $64.7m (FY, 2018) |
Cost of goods | Cost of goods N/A | Cost of goods $1.2m (FY, 2025) | Cost of goods N/A | Cost of goods ₹5.3b (FY, 2026) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $16.1m (FY, 2025) | Gross profit N/A | Gross profit ₹23.3b (FY, 2026) | Gross profit N/A |
Net income | Net income ($187.9m) (FY, 2022) | Net income ($102.1m) (FY, 2025) | Net income N/A | Net income ₹5.1b (FY, 2026) | Net income ($78.8m) (FY, 2018) |
Funding | |||||
Total funding raised | Total funding raised $ 171m | Total funding raised $ 56.2m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 122.8m |
For sources of this data, please see the company profile
View Company Profiles
Mesoblast
HQ
Melbourne, AU
Employees
73
Mesoblast specializes in the development of biologic products for the broad field of regenerative medicine.
View companySanesco
HQ
Arden, US
Employees
23
Sanesco Health International is a biomedical company providing healthcare practitioners with clinical tools and products used for neuroendocrine health.
View companyDr Lal PathLabs
HQ
Gurugram, IN
Employees
4,099
Dr Lal PathLabs is an international service provider of diagnostic and related healthcare tests.
View company
Spark Therapeutics
HQ
Philadelphia, US
Employees
368↑ 17% increase
Spark Therapeutics is a gene therapy company.
View company